Furthermore, LLL12 inhibited Twist1 [20], Notch-1, and Notch-3 [23] expression in ALDH+ breast cancer stem-like cells, which have recently been reported as STAT3 or Interleukin-6 target genes (Figure 2C). This evidence concerns the gene IL6 and breast cancer.